Background and objective: Chronic obstructive pulmonary disease (COPD) has potential origins in childhood but an association between childhood measles and postbronchodilator (BD) airflow obstruction (AO) has not yet been shown. We investigated whether childhood measles contributed to post-BD AO through interactions with asthma and/or smoking in a non-immunized middle-aged population. Methods: The population-based Tasmanian Longitudinal Health Study (TAHS) cohort born in 1961 (n = 8583) underwent spirometry in 1968 before immunization was introduced. A history of childhood measles infection was obtained from school medical records. During the fifth decade follow-up (n = 5729 responses), a subgroup underwent further lung function measurements (n = 1389). Relevant main associations and interactions by asthma and/or smoking on post-BD forced expiratory volume in 1 s/forced vital capacity (FEV 1 / FVC; continuous variable) and AO (FEV 1 /FVC < lower limit of normal) were estimated by multiple regression. Results: Sixty-nine percent (n = 950) had a history of childhood measles. Childhood measles augmented the combined adverse effect of current clinical asthma and smoking at least 10 pack-years on post-BD FEV 1 /FVC
INTRODUCTION
Early life factors have been implicated in the development of chronic obstructive pulmonary disease (COPD), 1, 2 primarily through reducing lung function growth during childhood. 3 This effectively reduces peak lung function which is attained by late adolescence/ early adulthood. 4 Theoretically, early life factors that lead to airway narrowing have the potential to predispose individuals to exhibit overt respiratory manifestations of asthma. Childhood respiratory infections have been known to predispose to airflow obstruction (AO) and reduced peak lung function, 5 and therefore have the potential to contribute to the severity of COPD later in life. 3 Specifically, early childhood viral infections such as respiratory syncytial virus have been linked to asthma and airflow limitation in older children. 6, 7 The long-term lung function consequences of the measles virus have not yet been established.
Three prospective population-based studies have examined the relationship between early childhood measles and post-bronchodilator (BD) spirometry in adults, all of which recruited participants born in the pre-antibiotic and pre-measles immunization era. [8] [9] [10] Although pneumonia is the most common severe acute complication of measles, 11 none of these studies reported main associations between childhood measles and adult post-BD AO. Shaheen et al. examined for effect modification by personal smoking in one cohort, but with insufficient power (n = 239). 10 Furthermore, none of the mentioned studies assessed associations with other measures of lung function related to COPD such as gas transfer factor and measures of gas trapping. We hypothesized that childhood measles contributed to reduced lung function in adult life, either by modifying the potential obstructive airway effects of adult asthma and/or smoking, 12, 13 or by contributing to lung parenchymal changes.
Using a prospective cohort study spanning five decades, we aimed to investigate the consequences of childhood measles with regards to post-BD lung function measures in middle age, and to investigate potential interactions with asthma and smoking. This manuscript is novel but complements a previous publication. 12 
METHODS

Study design and population
Participants were from the fifth decade follow-up of the Tasmanian Longitudinal Health Study (TAHS 1968 (TAHS -2008 , and details have been published, 12, [14] [15] [16] [17] [18] including the TAHS cohort profile paper. 18 Briefly, this population-based cohort born in 1961 (n = 8583) and studied with spirometry in 1968 was retraced (n = 7312), 17 and resurveyed (n = 5729 responses) between 2002 and 2005. Parent-completed school medical records which included history of childhood infections and immunizations were accessed. Those who participated at multiple time points (1974 clinical study and/or 1992 follow-up visit), and those with either adult asthma and/or chronic bronchitis based on the 2004 postal survey, were invited to participate in a clinical study (n = 2373) (Fig. 1) . 2 Of these, 1405 laboratory attendees underwent testing including post-BD spirometry (n = 1389), gas transfer factor and static lung volumes measurements. 
Data collection methods
Details of complex lung function testing have been described, 12 and are summarized in Appendix S1 (Supplementary Information). The measurements of lung function were standardized across testing sites following American Thoracic Society (ATS) and European Respiratory Society (ERS) standards. [19] [20] [21] For this analysis, lung function data from the baseline survey (1968) and laboratory study (2006) (2007) (2008) were converted to zscores.
12,22-24
Clinical definitions
A history of childhood measles was defined by an affirmative response by parents to a specific question recorded by the Tasmanian school medical service. Childhood current asthma was defined by the presence of asthma or 'wheezing breathing' within 2 years of lung function testing when participants were aged 6-7 years. Current clinical asthma was defined by a history of adult asthma and at least one of the asthma symptoms, medication use and/or healthcare utilization for asthma within 12 months preceding the laboratory study visit. Additional definitions are covered in Appendix S2 (Supplementary Information).
Post-BD AO (or post-BD AO) was defined by forced expiratory volume in 1 s/forced vital capacity (FEV 1 / FVC) < 5th percentile of normal predicted values (zscore < −1.645) following 200 μg of salbutamol administered via spacer, and its severity assessed. 25 Post-BD AO has been used synonymously with spirometrically defined COPD.
Statistical analysis
All analyses were carried out using Stata (release 14, Stata Corporation, College Station, TX, USA). Multivariable linear and logistic regression was used to examine the associations between childhood measles, post-BD AO and other lung function outcomes. Sampling weights, being the inverse of the probability of being included in the sample, were included in all prevalence estimates and regression models. Models were adjusted for a priori confounders and additionally adjusted for covariates that changed estimates of association by at least 10% (Appendix S3, Supplementary Information). Biologically plausible interactions (or multiplicative effects) were investigated and results were stratified if an interaction was present.
A conventional cut-off of P < 0.05 was used to determine statistical significance.
RESULTS
Demographic and clinical features
Clinical characteristics and lung function data for the laboratory study participants have been published. 12 Briefly, the mean age (SD) was 44.9 (0.85) years and 51% were male. As mentioned, our laboratory sample was intentionally enriched for ever having asthma and/or wheezing breathing in 67% (n = 925), of whom 36% (n = 335) had current clinical asthma. Over half were ever-smokers (57%, n = 804), of whom 59% (n = 457) had smoked at least 10 pack-years. The criterion for post-BD AO for the present analysis was met by 9.25% (n = 123) of the participants, of whom the majority had mild AO (n = 95, 77% of this physiological group).
A history of childhood measles infection was reported for 69% (n = 950) laboratory participants, and this did not differ by either adult or childhood current asthma status (P = 0.130 and P = 0.474, respectively; Table 1 ). Other than the deliberate enrichment for asthma and respiratory symptoms, laboratory study attendees were representative of the original 1968 cohort, especially including the prevalence of childhood measles (Table S1 , Supplementary Information).
Interactions on adult FEV 1 /FVC ratio
While we did not find a significant main association between childhood measles and post-BD FEV 1 /FVC ratio taken as a continuous variable (z-score: −0.10 to −0.11, P > 0.10; Table S2 (Supplementary Information)), we observed a two-way interaction between the effects of personal smoking and current asthma on post-BD FEV 1 /FVC ratio, but notably only for those with past childhood measles (three-way interaction: P = 0.009; Tables 2 and S2 (Supplementary Information)). Above the sum of individual asthma and smoking estimates, the excess reduction in absolute FEV 1 / FVC ratio attributed to childhood measles for eversmokers with ≥10 pack-year history and current clinical asthma was 6.4% of predicted.
This three-way interaction was relevant to those with early-onset current clinical asthma rather than lateonset asthma (three-way interaction: P = 0.011 and 0.198, respectively, data not shown). When restricted to only include participants who had childhood current asthma at mean age (SD) of 6.51 (0.28) years, the interaction was still significant despite relatively few regression numbers (n = 225, three-way interaction: P < 0.001).
A measles-related asthma-smoking interaction was also observed when post-BD AO was defined using the lower limit of normal (two-way interaction: P = 0.047; three-way interaction: P = 0.012) ( Table 3 ). This analysis differs from the continuous lung function outcome, mainly because the association between current clinical asthma without 10 pack-year history and post-BD AO did now differ significantly in the presence and absence of childhood measles, despite similar numbers with post-BD AO (OR: 2.23, n = 11 (P = 0.077) vs OR: 12.0, n = 14 (P < 0.001), respectively).
The estimates were relatively imprecise given modest regression numbers of post-BD AO (n = 95).
Population prevalence for adult AO
Given the observed three-way asthma-smokingmeasles interaction on post-BD AO, lung function summary statistics and prevalence of post-BD AO taken as the categorical variable have been stratified in Tables 4  and 5 , respectively. While the average population prevalence of post-BD AO in the reference group with and without measles was similar (column 2; Table 5 ), the 2 The present figure specifies how the subset of 1258 participants emerged from 1405 participating in the laboratory study (without reference to supplementary data). BD, bronchodilator.
adjusted post-BD AO prevalence for the asthmasmoking subgroup was significantly greater when there was also childhood measles (19% (95% CI: 4-34) vs 40% (27-52)). Paradoxically, the prevalence of post-BD AO was significantly less when the asthma-only subgroup was accompanied by childhood measles (18% (9-27) vs 8.1% (4-13)). Only 5.7% of laboratory participants had current adult asthma, ≥10 pack-years and measles, yet this subgroup represented 19% (95% CI: 13-28%) of participants with post-BD AO in the entire TAHS population.
Childhood measles and other lung function indices
No association between childhood measles and (pre-BD) spirometry when participants were 7 years old was seen (Supplementary Table S3 , Supplementary Information). A borderline association was seen between childhood measles and reduced transfer factor of the lung for carbon monoxide (T L CO) in middle age (zscore: −0.12 (−0.2 to −0.0005), P = 0.049, n = 994), but not for the static lung volume indices (Appendix S4, Supplementary Information).
DISCUSSION
In this prospective population-based study, childhood measles recorded by school medical report was not found to have an independent influence on post-BD AO in middle-aged individuals, but did augment substantially the combined effect of current asthma and smoking at least 10 pack-years. This three-way interaction was apparent from both decreasing post-BD FEV 1 / FVC ratio taken as a continuous variable and by increasing odds of 'spirometrically defined COPD'. Of this 'asthma-smoking-measles' subgroup comprising 5.7% of laboratory study participants, 40% had coexistent post-BD AO, and this profile contributed one-fifth of the total 'COPD' burden at this relatively young age. This primarily related to childhood-onset current adult asthma.
Measles-related lower respiratory tract involvement can frequently manifest as radiographic lung infiltrates in hospitalized children, 26 and the long-term sequelae of these changes have been poorly characterized. For instances of fatal measles infection, post-mortem studies have identified inflammation of 'fine' or smaller airways as a morphological feature distinct from lower lobe collapse and secondary bacterial pneumonia. 27 This raises the possibility that widespread small airway damage, inflammation and remodelling potentially arising from childhood measles predisposes to symptomatic asthma 24 and increased susceptibility to future respiratory insults like smoking. However, in addition to possible underlying primary structural tissue damage, the pathophysiology has been reported to include sustained measles-related immunological changes such as reductions in adult atopy. 28 The concept of an asthma-smoking interaction in relation to post-BD AO has been reported in our earlier work, 12 but importantly, modification by childhood measles is a novel finding. 29 The measles virus is highly contagious for all non-immunized individuals who have not had the disease, 30 and so was highly prevalent in this pre-immunization era group, but we found no independent effect of measles on its own. This suggests that from an epidemiological viewpoint, childhood measles might contribute towards causing disease together with other component causes, but is not sufficient to cause disease on its own. 31 In this prospective cohort, our group have shown a significant temporal relationship between childhood measles and subsequent asthma development in adolescence. 16 For middle-aged non-smokers and those smoking <10 pack-years, the present study suggests a link between current clinical asthma and post-BD AO differed by childhood measles status, which paradoxically seemed to protect against post-BD AO for those reporting measles by age 7 years (Table 3) . This is difficult to explain or even speculate but raises the possibility for measles-associated current adult asthma to be an asthma phenotype that is distinct from adult asthma without a measles history, given its lack of association with post-BD AO. Furthermore, the adverse obstructive smoking effect is so augmented in the presence of a substantial history, and required the co-presence of current adult asthma to see this. This potential for an infection to augment the influence of personal smoking seems quite similar to the clinical experience in tuberculosis.
32 Table 2 Interaction between the effects of childhood measles, current asthma and smoking on post-bronchodilator 6 to −1.1)*** Asthma-smoking interaction P = 0.520 P < 0.001 Asthma-smoking-measles interaction (three-way) P = 0.009 *P < 0.05; **P < 0.01; ***P < 0.001. † Reference group = those without current asthma who smoked less than a 10 pack-year history. ‡ Multivariable adjusted model includes sampling weights, sex, paternal occupation, familial and/or parental history of COPD/ asthma, pre-BD FEV 1 /FVC at age 7 years (continuous), maternal smoking, current asthma at age 7 years, adult atopy, plus the interaction term personal smoking × current asthma at age 45 years, stratified by measles infection.
§ No main effect for childhood measles infection per se on post-BD FEV 1 /FVC (Table S2 , Supplementary Information). ¶ A z-score is the deviation from the mean predicted value and is expressed by standard deviations, where 95% of normally distributed data lies between −1.96 SD and +1.96 SD.
BD, bronchodilator; FEV 1 /FVC, the ratio between forced expiratory volume in 1 s and forced vital capacity; Ref., reference group. 3, 40)*** Asthma-smoking interaction P = 0.109 P = 0.042 Asthma-smoking-measles interaction P = 0.012 *P < 0.05; **P < 0.01; ***P < 0.001. † Reference group = those without current asthma who smoked less than a 10 pack-year history. ‡ Multivariable adjusted model includes sampling weights, sex, paternal occupation, familial and/or parental history of COPD/ asthma, current asthma at age 7 years, pre-BD FEV 1 /FVC at age 7 years (binary), plus the three-way interaction term personal smoking × current asthma × childhood measles.
§ This column refers to the number of participants with post-BD AO (n) within individual measles/no measles subgroups, expressed as a percentage.
AO, airflow obstruction; BD, bronchodilator; FEV 1 /FVC, the ratio between forced expiratory volume in 1 s and forced vital capacity; n, number with post-BD AO; Ref., reference group.
We acknowledge that post-BD FEV 1 /FVC was only measured at one time point so longitudinal decline was not assessed. However, the complex interplay between childhood measles, adult current asthma and smoking history might in part explain why the TAHS has previously found a positive asthma-smoking interaction on post-BD AO while the Dunedin cohort study found a negative interaction for individuals who were born after the widespread availability of measles immunization. [33] [34] [35] While only a relatively small proportion of our middle-aged population comprised the asthma-smoking-measles subgroup, the magnitude of the lung function deficits and contribution to post-BD AO was considerable. For the era prior to measles immunization, this interaction might in part explain the previously observed heterogeneity of lung function loss for a given age, sex and pack-year history. This analysis raises the possibility that childhood measles might have a role in influencing the development of post-BD fig. 1 ). ‡ Lung function data are expressed as mean (SD), unless otherwise specified. § A z-score is the deviation from the mean predicted value and is expressed by standard deviations, where 95% of normally distributed data lies between −1.96 SD and +1.96 SD.
BD, bronchodilator; FEV 1 , forced expiratory volume in 1 s; FEV 1 /FVC, the ratio between FEV 1 and forced vital capacity. AO, especially for smokers with current asthma who may be more likely to progress to the 'asthma-COPD overlap (ACO)'. 36 If this is accurate, the introduction of measles immunization might well lessen the burden of post-BD AO for Australians born after 1970, which in the context of the marked drop off in smoking rates, has the potential for modifying future demographics of COPD in immunized communities.
Strengths and limitations
Our study has two main strengths: First, TAHS has collected data prospectively over five decades, from the age of 7 years until mid-adult life, with lung function measures that included static lung volumes and gas transfer factor. As TAHS participants were not immunized against measles and more than two-thirds had natural infection as young children, sufficient participant numbers allowed us to investigate complex interactions although some estimates were relatively imprecise. Second, while the 'healthy survivor effect' might have underestimated our observations, the older (pre-antibiotic) cohorts [8] [9] [10] would have been more susceptible to this form of bias.
In terms of limitations, it is acknowledged that it was not feasible to confirm the cases of childhood measles by serological testing. However, the TAHS school medical health records were completed by parents or guardians and highly experienced trained staff at a time when this childhood disease was highly prevalent and skilled clinical acuity was standard practice. As infections by measles may be more easily recalled if its occurrence was more recent and/or severe, our findings may not reflect milder and subclinical disease. While the lack of objective testing and diagnosis by a doctor may contribute to exposure misclassification, this most likely biases associations towards the null. Also, our analyses did not account for potential longterm obstructive lung effects from other infections such as respiratory syncytial virus, 6, 7 as this information was not collected, but again, this tends to weaken the signals.
While analyses were adjusted for sampling weights, it is possible that selection bias may not be entirely eliminated. Finally, as participants were essentially of European descent and unvaccinated for measles, this may limit the generalizability of our findings to nonCaucasian populations and adults born after 1970 in high-income countries. 33 In conclusion, we have found a novel interaction between the effects of childhood measles and the combination of current clinical asthma and smoking on a key diagnostic criterion for COPD in middle-aged adults. The lack of investigation into these interactions is likely to have resulted in null findings in previous studies. While we did not find measles to have an independent effect on its own, our stratification has raised the possibility of a measles-related adult asthma phenotype that most likely originated in childhood These findings, if replicated by others, may give rise to opportunities for 'personalized prevention', especially for developing countries which have high personal smoking rates 37 and are home to the majority of the world's unvaccinated children.
38 For observational populationbased cohorts, childhood measles infection and timing of immunization are considerations when studying the natural history of asthma and COPD.
